Renal NF-κB activation and TNF-α upregulation correlate with salt-sensitive hypertension in Dahl salt-sensitive rats

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 291, Issue 6, 2006, Pages

  Gu, Jian Wei ^a   Tian, Niu ^a   Shparago, Megan ^a   Tan, Wei ^a   Bailey, Amelia P ^a   Manning Jr , R Davis ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Inflammation; Kidneys; Nuclear factor B; Tumor necrosis factor

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; ELECTROPHORETIC MOBILITY; HYPERTENSION; MALE; MOLECULAR MECHANICS; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RAT; SODIUM APPETITE; UPREGULATION; ANIMAL; CHEMICALLY INDUCED DISORDER; DAHL SALT SENSITIVE RAT; METABOLISM; RENOVASCULAR HYPERTENSION; SALT INTAKE; STATISTICS; TRANSACTIVATION;

ANIMALS; HYPERTENSION, RENAL; MALE; NEPHRITIS; NF-KAPPA B; RATS; RATS, INBRED DAHL; SODIUM CHLORIDE, DIETARY; STATISTICS; TRANS-ACTIVATION (GENETICS); TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 33845391266     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00153.2006     Document Type: Article

References (46)

1. Alvarez V, Quirz Y, Nava M, Pons H, and Rodriguez-Iturbe B. Overload proteinuria is followed by salt-sensitive hypertension caused by renal infiltration of immune cells. Am J Physiol Renal Physiol 283: F1132-F1141, 2002.
2. Aviv A. Salt and hypertension: the debate that begs the bigger question. Arch Intern Med 161: 507-510, 2001.
3. Baeuerle PA and Henkle T. Function and activation of NFκB in the immune system. Annu Rev Immunol 12: 141-179, 1994.
4. Baldwin AS. The NFκB and IκB proteins: new discoveries and insights. Annu Rev Immunol 14: 649-681, 1996.
5. Barnes PJ and Karin M. Nuclear factor-kappa B: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336: 1066-1071, 1997.
6. Beswick RA, Zhang H, Marable D, Catravas JD, Hill WD, and Webb RC. Long-term antioxidant administration attenuates mineralocorticoid hypertension and renal inflammatory response. Hypertension 37: 781-786, 2001.
7. Campese VM. Salt sensitivity in hypertension. Renal and cardiovascular implications. Hypertension 23: 531-550, 1994.
8. Dahl LK, Heine M, and Tassinari L. Role of genetic factors in susceptibility to experimental hypertension due to chronic excess salt ingestion. Nature 194: 480-482, 1962.
9. Dahly AJ, Hoagland KM, Flasch AK, Jha S, Ledbetter SR, and Roman RJ. Antihypertensive effects of chronic anti-TGF-β antibody therapy in Dahl S rats. Am J Physiol Regul Integr Comp Physiol 283: R757-R767, 2002.
10. Dahly-Vernon AJ, Sharma M, McCarthy ET, Savin VJ, Ledbetter SR, and Roman RJ. Transforming growth factor-β, 20-HETE interaction, and glomerular injury in Dahl salt-sensitive rats. Hypertension 45: 643-648, 2005.
11. Frohlich ED and Varagic J. Sodium directly impairs target organ function in hypertension. Curr Opin Cardiol 20: 424-429, 2005.
12. Ghosh S, May M, and Kopp E. NFκB and Rel proteins: evolutionarily conserved mediators of the immune response. Annu Rev Immunol 16: 225-260, 1998.
13. Gu JW, Anand V, Shek EW, Moore MC, Brady AL, Kelly WC, and Adair TH. Sodium induces hypertrophy of cultured myocardial myoblasts and vascular smooth muscle cells. Hypertension 31: 1083-1087, 1998.
14. Guijarro C and Egido J. Transcription factor-κB (NFκB) and renal disease. Kidney Int 59: 415-424, 2001.
15. Jacob HJ and Kwitek AE. Rat genetics: attaching physiology and pharmacology to the genome. Nat Rev Genet 3: 33-42, 2002.
16. Johnson RJ, Herrera-Acosta J, Schreiner GF, and Rodriguez-Iturbe B. Subtle acquired renal injury as a mechanism of salt-sensitive hypertension. N Engl J Med 346: 913-923, 2002.
17. Klag MJ, Wheltn PK, Randall BL, Neaton JD, Brancati FL, Ford CE, Shulman NB, and Stamler J. Blood pressure and end-stage renal disease in men. N Engl J Med 334: 13-18, 1996.
18. Kobori H, Nishiyama A, Abe Y, and Navar G. Enhancement of intrarenal angiotensinogen in Dahl salt-sensitive rats on high salt diet. Hypertension 41: 592-597, 2003.
19. Kobori H and Nishiyama A. Effects of tempol on renal angiotensinogen production in Dahl salt-senstive rats. Biochem Biophys Res Commun 315: 746-750, 2004.
20. Krappmann D, Wulczyn FG, and Scheidereit C. Different mechanisms control signal-induced degradation and basal turnover of the NFκB inhibitor IκBα in vivo. EMBO J 15: 6716-6726, 1996.
21. Li J and Brasier AR. Angiotensinogen gene activation by angiotensin II is mediated by the rel A (nuclear factor-κB p65) transcription factor: one mechanism for the renin angiotensin system positive feedback loop in hepatocytes. Mol Endocrinol 10: 252-264, 1996.
22. Manning RD Jr, Tian N, and Meng S. Oxidative stress and antioxidant treatment in hypertension and the associated renal damage. Am J Nephrol 25: 311-317, 2005.
23. Manning RD Jr, Meng S, and Tian N. Renal and vascular oxidative stress and salt-sensitivity of arterial pressure. Acta Physiol Scand 179: 243-250, 2003.
24. Meng S, Gason GW, Gannon AW, and Manning RD Jr. Oxidative stress in Dahl salt-sensitive hypertension. Hypertension 41: 1346-1352, 2003;.
25. Mervaala E, Finckenberg P, Lapatto R, Muller DN, Park JK, Dechend R, Ganten D, Vapaatalo H, and Luft FC. Lipoic acid supplementation prevents angiotensin II-induced renal injury. Kidney Int 64: 501-508, 2003;.
26. Morimoto A, Uzu T, Fujii T, Nishimura M, Kuroda S, Nakamura S, Inenaga T, and Kimura G. Sodium sensitivity and cardiovascular events in patients with essential hypertension. Lancet 350: 1734-1737, 1997.
27. Muller DN, Dechend R, Mervaala EMA, Park JK, Schmidt F, Fiebeler A, Theuer J, Breu V, Ganten D, Haller H, and Luft FC. NF-κB inhibition ameliorates angiogensin II-induced inflammatory damage in rats. Hypertension 35: 193-201, 2000.
28. Nakamichi K, Saiki M, Sawada M, Takayama-Ito M, Yamamuro Y, Morimoto K, and Jurane I. Rabies virus-induced activation of mitogen-activated protein kinase and NF-kappaB signaling pathways regulates expression of CXC and CC chemokine ligands in microglia. J Virol 79: 11801-11812, 2005.
29. Nava M, Quiroz Y, Vaziri N, and Rodriguez-Iturbe B. Melatonin reduces renal interstitial inflammation and improves hypertension in spontaneously hypertensive rats. Am J Physiol Renal Physiol 284: F447-F454, 2003.
30. 1 receptors on glomerular injury in Dahl salt-sensitive rats. Am J Physiol Regul Integr Comp Physiol 274: R1797-R1806, 1998.
31. Praga M and Morales E. Renal damage associated with proteinuria. Kidney Int 62: S42-S46, 2002.
32. Rapp JP. Genetic analysis of inherited hypertension in the rat. Physiol Rev 80: 135-172, 2000.
33. Rodriguez-Iturbe B, Herrera-Acosta J, and Johnson R. Interstitial inflammation, sodium retention, and the pathogenesis of nephrotic edema: a unifying hypothesis. Kidney Int 62: 1379-1384, 2002.
34. Rodriguez-Iturbe B, Pons H, Quiroz Y, Gordon K, Rincon J, Chavez M, Parra G, Herrera-Acosta J, Gomez-Garre D, Largo R, Egido J, and Johnson RJ. Mycophenolate mofetil prevents salt-sensitive hypertension resulting angiotensin II exposure. Kidney Int 59: 2222-2232, 2001.
35. Rodriguez-Iturbe B, Quiroz Y, Nava M, Bonet L, Chavez M, Herrera-Acosta J, Johnson RJ, and Pons HA. Reduction of renal immune cell infiltration results in blood pressure control in genetically hypertensive rats. Am J Physiol Renal Physiol 282: F191-F201, 2002.
36. Romero JA and Reckelhoff JF. Role of angiotensin and oxidative stress in arterial hypertension. Hypertension 34: 943-949, 1999.
37. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller 3rd ER, Simons-Morton DG, Karanja N, and Lin PH. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. SASH-Sodium Collaborative Research Group. N Engl J Med 344: 3-10, 2001.
38. Shen K, DeLano FA, Zweifach BW, and Schmid-Schönbein GW. Circulating leukocyte counts, activation, and degranulation in Dahl hypertensive rats. Circ Res 76: 276-283, 1995.
39. Siegel AK, Kossmehl P, Planer M, Schulz A, Wehland M, Stoll M, Bruijin JA, de Heer E, and Kreutz R. Genetic linkage of albuminuria and renal injury in Dahl salt-sensitive rats on a high-salt diet: comparison with spontaneously hypertensive rats. Physiol Genomics 18: 218-225, 2004.
40. Somers MJ, Mavromatis K, Galis ZS, and Harrison DG. Vascular superoxide production and vasomotor function in hypertension induced by deoxycorticosterone acetate-salt. Circulation 101: 1722-1728, 2000.
41. Swei A, Lacy F, DeLano FA, and Schmid-Schonbein GW. Oxidative stress in the Dahl hypertensive rat. Hypertension 30: 1628-1633, 1997.
42. Swei A, Lacy F, DeLano FA, Parks DA, and Schmid-Schonbein GW. A mechanism of oxygen free radical production in the Dahl hypertensive rat. Microcirculation 6: 179-187, 1999;.
43. 2+/calcineurin signaling pathways. J Biol Chem 279: 44606-44612, 2004.
44. Weinberger MH, Fineberg NS, Fineberg SE, and Weingerger M. Salt sensitivity, pulse pressure, and death in normal and hypertensive humans. Hypertension 37: 429-432, 2001.
45. Wilcox CS. Reactive oxygen species: roles in blood pressure and kidney function. Curr Hypertens Rep 4: 160-166, 2002.
46. Zoja C, Donadelli R, Colleoni S, Figliuzzi M, Bonazzola S, Morigi M, and Remuzzi G. Protein overload stimulates RANTES production by proximal tubular cells depending on NFκB activation. Kidney Int 53: 1608-1615, 1998.